Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Family History Not Linked to Clinical Presentation, Treatment Response of RA

Will Boggs, MD  |  July 16, 2015

NEW YORK (Reuters Health)—Having a family history of rheumatoid arthritis (RA) does not appear to influence the clinical presentation or treatment response of RA to standard medications, researchers from Sweden report. “At first we were a bit surprised by our findings,” Dr. Thomas Frisell from Karolinska Institutet in Stockholm told Reuters Health by email. “Patients…

Filed under:ConditionsRheumatoid Arthritis Tagged with:genetic riskgeneticsMethotrexateRheumatoid Arthritis (RA)TNF inhibitors

Teriparatide to Denosumab Switch Helpful in Osteoporosis

David Douglas  |  July 16, 2015

NEW YORK (Reuters Health)—In postmenopausal osteoporotic women, changing from teriparatide to denosumab benefits bone mineral density (BMD) but switching from denosumab to teriparatide may result in bone loss, according to new research. In a July 3 online paper in The Lancet, Dr. Benjamin Z. Leder, of Massachusetts General Hospital, Boston, and colleagues noted that many…

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:Amgenbone lossbone mineral density (BMD)denosumabNational Institutes of Health (NIH)Osteoporosisosteoporosis treatmentsteriparatideteriparatide treatment for osteoporosis

On Research Review Boards, Conflict-of-Interest Reporting Improves

Kathryn Doyle  |  July 16, 2015

(Reuters Health)—Many doctors who serve on hospital panels overseeing the ethics and safety of human research trials have industry relationships that may compromise their objectivity, but reporting these conflicts has become more common over the past 10 years, according to a new study. Physicians who serve on so-called institutional review boards (IRBs) may also be…

Filed under:EthicsProfessional Topics Tagged with:Ethicsphysician

Greece Bans Export of 25 Drugs after Pharmacists’ Supply Warnings

Lefteris Karagiannopoulos  |  July 15, 2015

ATHENS (Reuters)—Greece has decided to ban the export of 25 types of drugs, the Health Ministry said on Tuesday, following warnings by pharmacists that they faced difficulties in securing some supplies. A ministry spokeswoman said the Greek drugs regulator had told a meeting at the ministry on Friday—when the pharmacists made their warnings—that there had…

Filed under:Drug Updates Tagged with:Drug shortageEuropean UnionGreece

Phase 3 Studies Evaluate Lesinurad for Gout Treatment

Michele B. Kaufman, PharmD, BCGP  |  July 15, 2015

For 12 months, two studies examined the use of lesinurad in combination with allopurinol to treat gout, with patients achieving reduced serum uric acid levels and demonstrating no severe toxicity.

Filed under:ConditionsDrug UpdatesEULAR/OtherGout and Crystalline ArthritisMeeting Reports Tagged with:AllopurinolEULARGoutlesinurad

Prepare NOW for ICD-10 Medical Coding Transition

Prepare NOW for ICD-10 Medical Coding Transition

Kimberly Retzlaff  |  July 14, 2015

The ICD-10 page on the Centers for Medicare & Medicaid Services (CMS) website features a countdown clock that shows the time left until Oct. 1, 2015, the date on which compliance with the new code set becomes mandatory. By the time this issue goes to press, the clock will read 90 or fewer days. Time…

Filed under:Billing/CodingPractice Support Tagged with:BillingCodingDocumentationICD-10medicalPractice Managementrheumatologisttransition

Healthcare Office Design, Staff Can Make Good Impression on Patients

Healthcare Office Design Can Make a Positive Difference for Rheumatology Patients

Karen Appold  |  July 14, 2015

When designing healthcare spaces to foster wellness, you should first understand the particular patient illness being served and then determine that population’s fundamental needs. “Providers who serve patients with rheumatoid conditions should identify the range of clinical presentations specific to their patient population,” advises Sharon E. Woodworth, AIA, ACHA, EDAC, Healthcare Practice Leader, Perkins+Will Architects,…

Filed under:Practice Support Tagged with:office visitpatient carerheumatologist

Polymyalgia Rheumatica Misdiagnosis Results in Positive Outcome

Hiroshi Watanabe, MD, PhD  |  July 14, 2015

In late February 2011, a 68-year-old woman visited the rheumatology outpatient clinic. She had been congenitally healthy and had been a field athlete in her early days. Beginning in early January 2011, she became aware of pain in her neck and both shoulders, with pain spreading to her lower back and thighs. She also became…

Filed under:ConditionsSoft Tissue Pain Tagged with:DiagnosisoutcomePainpatient carePolymyalgia RheumaticaTreatment

The ACR’s State-of-the-Art Clinical Symposium: Patients with Scleroderma, Lung Disease May Benefit from Aggressive Therapy

Thomas R. Collins  |  July 14, 2015

CHICAGO—Scleroderma patients with pulmonary arterial hypertension (PAH) might benefit from more aggressive therapy, an expert in the field said in a session on lung involvement in rheumatic diseases at the American College of Rheumatology’s 2015 State-of-the-Art Clinical Symposium in May. Newer trials—the SERAPHIN trial on macitentan, GRIPHON on selexipag, and AMBITION on an ambrisentan/tadalafil combination—show…

Filed under:ConditionsEducation & TrainingMeeting ReportsProfessional TopicsResearch RheumSystemic Sclerosis Tagged with:AC&Rclinical symposiumlung diseasepulmonary arterial hypertensionResearchSclerodermatherapy

The ACR’s State-of-the-Art Clinical Symposium: Rheumatologists Weigh in on Tough-to-Treat Cases, Paget’s Disease, Imaging

Thomas R. Collins  |  July 14, 2015

CHICAGO—A 49-year-old woman has had RA for eight years. She has a rheumatoid factor reading of 35, an aCCP reading of 160, erythrocyte sedimentation rate of 42, plus erosions. She has been on methotrexate. She tried etanercept for six months, but then it stopped working. She was on 40 mg of adalimumab weekly, but it…

Filed under:ConditionsMeeting Reports Tagged with:combination therapydrugimagingoutcomePaget’s diseasepatient careRheumatic Diseaserheumatologisttoxicity

  • « Previous Page
  • 1
  • …
  • 238
  • 239
  • 240
  • 241
  • 242
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences